Report cover image

Antidiarrheal Microorganisms Industry Research Report 2025

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 133 Pages
SKU # APRC20260560

Description

Summary

According to APO Research, the global Antidiarrheal Microorganisms market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Antidiarrheal Microorganisms is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Antidiarrheal Microorganisms is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Antidiarrheal Microorganisms is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Antidiarrheal Microorganisms include Zhejiang Jingxin Pharmaceutical Co., Ltd., Shanghai SPH Xinyi Pharmaceutical Co., Ltd., Inner Mongolia Shuangqi Pharmaceutical Co., Ltd., Livzon Pharmaceutical Factory of Livzon Group, Sinovac Biotech Co., Ltd., Jincheng Haisi Pharmaceutical Co., Ltd., Hangzhou Yuanda Biopharmaceutical Co., Ltd., Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. and Beijing Hanmei Pharmaceutical Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Antidiarrheal Microorganisms, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidiarrheal Microorganisms.

The report will help the Antidiarrheal Microorganisms manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Antidiarrheal Microorganisms market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antidiarrheal Microorganisms market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Antidiarrheal Microorganisms Segment by Company

Zhejiang Jingxin Pharmaceutical Co., Ltd.
Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
Livzon Pharmaceutical Factory of Livzon Group
Sinovac Biotech Co., Ltd.
Jincheng Haisi Pharmaceutical Co., Ltd.
Hangzhou Yuanda Biopharmaceutical Co., Ltd.
Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
Beijing Hanmei Pharmaceutical Co., Ltd.
VWR
Vermicon AG
Tangsonsbio
Pepto Bismol
Goerlich Pharma
Chr. Hansen
Biofermin
Aptalis Pharma SAS
Antidiarrheal Microorganisms Segment by Type

Bifidobacterium Live Bacteria
Bacillus Subtilis Live Bacteria
Bacillus Licheniformis Live Bacteria
Other
Antidiarrheal Microorganisms Segment by Application

Pharmacy
Hospital
Clinic
Other
Antidiarrheal Microorganisms Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidiarrheal Microorganisms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antidiarrheal Microorganisms and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidiarrheal Microorganisms.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antidiarrheal Microorganisms manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antidiarrheal Microorganisms by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antidiarrheal Microorganisms in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

133 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Antidiarrheal Microorganisms Market Size (2020-2031)
2.2.2 Global Antidiarrheal Microorganisms Sales (2020-2031)
2.2.3 Global Antidiarrheal Microorganisms Market Average Price (2020-2031)
2.3 Antidiarrheal Microorganisms by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Bifidobacterium Live Bacteria
2.3.3 Bacillus Subtilis Live Bacteria
2.3.4 Bacillus Licheniformis Live Bacteria
2.3.5 Other
2.4 Antidiarrheal Microorganisms by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Pharmacy
2.4.3 Hospital
2.4.4 Clinic
2.4.5 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global Antidiarrheal Microorganisms Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Antidiarrheal Microorganisms Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Antidiarrheal Microorganisms Revenue of Manufacturers (2020-2025)
3.4 Global Antidiarrheal Microorganisms Average Price by Manufacturers (2020-2025)
3.5 Global Antidiarrheal Microorganisms Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Antidiarrheal Microorganisms, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Antidiarrheal Microorganisms, Product Type & Application
3.8 Global Manufacturers of Antidiarrheal Microorganisms, Established Date
3.9 Global Antidiarrheal Microorganisms Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zhejiang Jingxin Pharmaceutical Co., Ltd.
4.1.1 Zhejiang Jingxin Pharmaceutical Co., Ltd. Company Information
4.1.2 Zhejiang Jingxin Pharmaceutical Co., Ltd. Business Overview
4.1.3 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Zhejiang Jingxin Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.1.5 Zhejiang Jingxin Pharmaceutical Co., Ltd. Recent Developments
4.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd.
4.2.1 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Company Information
4.2.2 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Business Overview
4.2.3 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.2.5 Shanghai SPH Xinyi Pharmaceutical Co., Ltd. Recent Developments
4.3 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd.
4.3.1 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Company Information
4.3.2 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Business Overview
4.3.3 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.3.5 Inner Mongolia Shuangqi Pharmaceutical Co., Ltd. Recent Developments
4.4 Livzon Pharmaceutical Factory of Livzon Group
4.4.1 Livzon Pharmaceutical Factory of Livzon Group Company Information
4.4.2 Livzon Pharmaceutical Factory of Livzon Group Business Overview
4.4.3 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Livzon Pharmaceutical Factory of Livzon Group Antidiarrheal Microorganisms Product Portfolio
4.4.5 Livzon Pharmaceutical Factory of Livzon Group Recent Developments
4.5 Sinovac Biotech Co., Ltd.
4.5.1 Sinovac Biotech Co., Ltd. Company Information
4.5.2 Sinovac Biotech Co., Ltd. Business Overview
4.5.3 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Sinovac Biotech Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.5.5 Sinovac Biotech Co., Ltd. Recent Developments
4.6 Jincheng Haisi Pharmaceutical Co., Ltd.
4.6.1 Jincheng Haisi Pharmaceutical Co., Ltd. Company Information
4.6.2 Jincheng Haisi Pharmaceutical Co., Ltd. Business Overview
4.6.3 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Jincheng Haisi Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.6.5 Jincheng Haisi Pharmaceutical Co., Ltd. Recent Developments
4.7 Hangzhou Yuanda Biopharmaceutical Co., Ltd.
4.7.1 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Company Information
4.7.2 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Business Overview
4.7.3 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.7.5 Hangzhou Yuanda Biopharmaceutical Co., Ltd. Recent Developments
4.8 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd.
4.8.1 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Company Information
4.8.2 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Business Overview
4.8.3 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.8.5 Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. Recent Developments
4.9 Beijing Hanmei Pharmaceutical Co., Ltd.
4.9.1 Beijing Hanmei Pharmaceutical Co., Ltd. Company Information
4.9.2 Beijing Hanmei Pharmaceutical Co., Ltd. Business Overview
4.9.3 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Beijing Hanmei Pharmaceutical Co., Ltd. Antidiarrheal Microorganisms Product Portfolio
4.9.5 Beijing Hanmei Pharmaceutical Co., Ltd. Recent Developments
4.10 VWR
4.10.1 VWR Company Information
4.10.2 VWR Business Overview
4.10.3 VWR Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.10.4 VWR Antidiarrheal Microorganisms Product Portfolio
4.10.5 VWR Recent Developments
4.11 Vermicon AG
4.11.1 Vermicon AG Company Information
4.11.2 Vermicon AG Business Overview
4.11.3 Vermicon AG Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.11.4 Vermicon AG Antidiarrheal Microorganisms Product Portfolio
4.11.5 Vermicon AG Recent Developments
4.12 Tangsonsbio
4.12.1 Tangsonsbio Company Information
4.12.2 Tangsonsbio Business Overview
4.12.3 Tangsonsbio Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.12.4 Tangsonsbio Antidiarrheal Microorganisms Product Portfolio
4.12.5 Tangsonsbio Recent Developments
4.13 Pepto Bismol
4.13.1 Pepto Bismol Company Information
4.13.2 Pepto Bismol Business Overview
4.13.3 Pepto Bismol Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Pepto Bismol Antidiarrheal Microorganisms Product Portfolio
4.13.5 Pepto Bismol Recent Developments
4.14 Goerlich Pharma
4.14.1 Goerlich Pharma Company Information
4.14.2 Goerlich Pharma Business Overview
4.14.3 Goerlich Pharma Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Goerlich Pharma Antidiarrheal Microorganisms Product Portfolio
4.14.5 Goerlich Pharma Recent Developments
4.15 Chr. Hansen
4.15.1 Chr. Hansen Company Information
4.15.2 Chr. Hansen Business Overview
4.15.3 Chr. Hansen Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Chr. Hansen Antidiarrheal Microorganisms Product Portfolio
4.15.5 Chr. Hansen Recent Developments
4.16 Biofermin
4.16.1 Biofermin Company Information
4.16.2 Biofermin Business Overview
4.16.3 Biofermin Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Biofermin Antidiarrheal Microorganisms Product Portfolio
4.16.5 Biofermin Recent Developments
4.17 Aptalis Pharma SAS
4.17.1 Aptalis Pharma SAS Company Information
4.17.2 Aptalis Pharma SAS Business Overview
4.17.3 Aptalis Pharma SAS Antidiarrheal Microorganisms Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Aptalis Pharma SAS Antidiarrheal Microorganisms Product Portfolio
4.17.5 Aptalis Pharma SAS Recent Developments
5 Global Antidiarrheal Microorganisms Market Scenario by Region
5.1 Global Antidiarrheal Microorganisms Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Antidiarrheal Microorganisms Sales by Region: 2020-2031
5.2.1 Global Antidiarrheal Microorganisms Sales by Region: 2020-2025
5.2.2 Global Antidiarrheal Microorganisms Sales by Region: 2026-2031
5.3 Global Antidiarrheal Microorganisms Revenue by Region: 2020-2031
5.3.1 Global Antidiarrheal Microorganisms Revenue by Region: 2020-2025
5.3.2 Global Antidiarrheal Microorganisms Revenue by Region: 2026-2031
5.4 North America Antidiarrheal Microorganisms Market Facts & Figures by Country
5.4.1 North America Antidiarrheal Microorganisms Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Antidiarrheal Microorganisms Sales by Country (2020-2031)
5.4.3 North America Antidiarrheal Microorganisms Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Antidiarrheal Microorganisms Market Facts & Figures by Country
5.5.1 Europe Antidiarrheal Microorganisms Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Antidiarrheal Microorganisms Sales by Country (2020-2031)
5.5.3 Europe Antidiarrheal Microorganisms Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Antidiarrheal Microorganisms Market Facts & Figures by Country
5.6.1 Asia Pacific Antidiarrheal Microorganisms Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Antidiarrheal Microorganisms Sales by Country (2020-2031)
5.6.3 Asia Pacific Antidiarrheal Microorganisms Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Antidiarrheal Microorganisms Market Facts & Figures by Country
5.7.1 South America Antidiarrheal Microorganisms Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Antidiarrheal Microorganisms Sales by Country (2020-2031)
5.7.3 South America Antidiarrheal Microorganisms Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Antidiarrheal Microorganisms Market Facts & Figures by Country
5.8.1 Middle East and Africa Antidiarrheal Microorganisms Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Antidiarrheal Microorganisms Sales by Country (2020-2031)
5.8.3 Middle East and Africa Antidiarrheal Microorganisms Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global Antidiarrheal Microorganisms Sales by Type (2020-2031)
6.1.1 Global Antidiarrheal Microorganisms Sales by Type (2020-2031) & (K Units)
6.1.2 Global Antidiarrheal Microorganisms Sales Market Share by Type (2020-2031)
6.2 Global Antidiarrheal Microorganisms Revenue by Type (2020-2031)
6.2.1 Global Antidiarrheal Microorganisms Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Antidiarrheal Microorganisms Revenue Market Share by Type (2020-2031)
6.3 Global Antidiarrheal Microorganisms Price by Type (2020-2031)
7 Segment by Application
7.1 Global Antidiarrheal Microorganisms Sales by Application (2020-2031)
7.1.1 Global Antidiarrheal Microorganisms Sales by Application (2020-2031) & (K Units)
7.1.2 Global Antidiarrheal Microorganisms Sales Market Share by Application (2020-2031)
7.2 Global Antidiarrheal Microorganisms Revenue by Application (2020-2031)
7.2.1 Global Antidiarrheal Microorganisms Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Antidiarrheal Microorganisms Revenue Market Share by Application (2020-2031)
7.3 Global Antidiarrheal Microorganisms Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Antidiarrheal Microorganisms Value Chain Analysis
8.1.1 Antidiarrheal Microorganisms Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Antidiarrheal Microorganisms Production Mode & Process
8.2 Antidiarrheal Microorganisms Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Antidiarrheal Microorganisms Distributors
8.2.3 Antidiarrheal Microorganisms Customers
9 Global Antidiarrheal Microorganisms Analyzing Market Dynamics
9.1 Antidiarrheal Microorganisms Industry Trends
9.2 Antidiarrheal Microorganisms Industry Drivers
9.3 Antidiarrheal Microorganisms Industry Opportunities and Challenges
9.4 Antidiarrheal Microorganisms Industry Restraints
10 Report Conclusion
11 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.